Giving babies the best start for the rest of their lives...

Safety of Clindamycin, Ampicillin, Metronidazole, and Piperacillin-tazobactam- SCAMP


These are antibacterial antibiotics with activity against bacterial pathogens associated with intra-abdominal infections.They also happen to be poorly studied in neonates, particularly preterm neonates. The NICHD2 is sponsoring this multicenter study that will evaluate these antibiotics in babies with complicated intra-abdominal infections Sharp Mary Birch is a study site among 50 centers around the country and Canada.


The main purpose of this study is evaluate whether it is safe or not to use various combination of antibiotics (ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, gentamicin) in treating infants with complicated intra-abdominal infections

Who to contact if you want more information

The Research Team will be contacting you regarding your interest in this study. 

You may also contact the Sharp Mary Birch Neonatal Intensive Care Unit (NICU) at:

 858 939-4298, or NICU Research Offices at:  858 939-4112

To contact e-mail: